JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 1.920
0.00 (0.00%)
Jul 31, 2026, 3:30 PM HKT
JBM (Healthcare) Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 834.63 | 782.29 | 648.42 | 520.32 | 406.14 | |
Revenue Growth | 6.69% | 20.65% | 24.62% | 28.12% | 2.26% |
Cost of Revenue | 369.1 | 368.59 | 310.33 | 314.81 | 244.63 |
Gross Profit | 465.54 | 413.71 | 338.08 | 205.51 | 161.51 |
Selling, General & Admin | 211.85 | 185.74 | 180.21 | 137.74 | 122.65 |
Other Operating Expenses | -10.4 | -5.61 | -4.37 | -2.71 | -2.44 |
Operating Expenses | 201.45 | 180.13 | 175.85 | 135.03 | 120.21 |
Operating Income | 264.09 | 233.58 | 162.24 | 70.48 | 41.31 |
Interest Expense | -11.69 | -4.46 | -8.5 | -8.21 | -6.41 |
Interest & Investment Income | 0.8 | 1.57 | 0.76 | 0.27 | 0.02 |
Earnings From Equity Investments | 0.05 | 0.07 | -0.82 | -1.93 | -1.79 |
Currency Exchange Gain (Loss) | -2.11 | 9.19 | 6.74 | 2.43 | 0.13 |
EBT Excluding Unusual Items | 251.15 | 239.94 | 160.43 | 63.03 | 33.26 |
Gain (Loss) on Sale of Investments | - | - | 4.47 | - | - |
Gain (Loss) on Sale of Assets | -0.63 | 0.9 | -0.01 | 8.77 | -0.01 |
Asset Writedown | - | - | - | - | -2.5 |
Other Unusual Items | 1.63 | 0.83 | - | 5.09 | - |
Pretax Income | 252.15 | 241.67 | 164.89 | 76.9 | 30.75 |
Income Tax Expense | 41.84 | 38.98 | 27.68 | 13.57 | 7.42 |
Earnings From Continuing Operations | 210.31 | 202.69 | 137.21 | 63.33 | 23.33 |
Minority Interest in Earnings | -9.22 | -5.43 | -6.75 | -6.24 | 1.29 |
Net Income | 201.09 | 197.26 | 130.46 | 57.09 | 24.62 |
Net Income to Common | 201.09 | 197.26 | 130.46 | 57.09 | 24.62 |
Net Income Growth | 1.94% | 51.20% | 128.51% | 131.90% | 8.94% |
Shares Outstanding (Basic) | 817 | 819 | 884 | 891 | 894 |
Shares Outstanding (Diluted) | 817 | 819 | 884 | 891 | 894 |
Shares Change | -0.32% | -7.30% | -0.86% | -0.26% | 9.79% |
EPS (Basic) | 0.25 | 0.24 | 0.15 | 0.06 | 0.03 |
EPS (Diluted) | 0.25 | 0.24 | 0.15 | 0.06 | 0.03 |
EPS Growth | 2.27% | 63.11% | 130.48% | 132.92% | -0.95% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 129.1 | 205.92 | 181 | 137.48 | 52.94 |
Free Cash Flow Per Share | 0.16 | 0.25 | 0.20 | 0.15 | 0.06 |
Dividend Per Share | 0.171 | 0.170 | 0.075 | 0.030 | - |
Dividend Growth | 0.59% | 126.67% | 150.00% | - | - |
Gross Margin | 55.78% | 52.88% | 52.14% | 39.50% | 39.77% |
Operating Margin | 31.64% | 29.86% | 25.02% | 13.54% | 10.17% |
Profit Margin | 24.09% | 25.22% | 20.12% | 10.97% | 6.06% |
Free Cash Flow Margin | 15.47% | 26.32% | 27.91% | 26.42% | 13.03% |
EBITDA | 293.13 | 270.56 | 195.48 | 100.99 | 74.9 |
EBITDA Margin | 35.12% | 34.59% | 30.15% | 19.41% | 18.44% |
D&A For EBITDA | 29.04 | 36.98 | 33.24 | 30.52 | 33.6 |
EBIT | 264.09 | 233.58 | 162.24 | 70.48 | 41.31 |
EBIT Margin | 31.64% | 29.86% | 25.02% | 13.54% | 10.17% |
Effective Tax Rate | 16.59% | 16.13% | 16.79% | 17.65% | 24.12% |